Skip to main content
Top
Published in: Abdominal Radiology 4/2012

01-08-2012

Peritoneal carcinomatosis: imaging with 64-MDCT and 3T MRI with diffusion-weighted imaging

Authors: F. Iafrate, M. Ciolina, P. Sammartino, P. Baldassari, M. Rengo, P. Lucchesi, S. Sibio, F. Accarpio, A. Di Giorgio, A. Laghi

Published in: Abdominal Radiology | Issue 4/2012

Login to get access

Abstract

Peritoneal carcinomatosis is usually associated with a poor overall survival rate. Recently, introduction of more aggressive surgical treatment and intraperitoneal chemotherapy appears to significantly increase the overall survival rate for these patients. A detailed preoperative assessment of peritoneal carcinomatosis could be very challenging in the field of imaging, but a new aggressive surgical approach requires an accurate preoperative assessment of the disease. Cross-sectional imaging using CT and MRI with diffusion-weighted imaging (DWI) sequences is important for appropriate management of patients with peritoneal carcinomatosis. Appreciation of the spectrum of diagnostic patterns and pitfalls as well as different sites of involvement of peritoneal carcinomatosis using CT and DWI is crucial for appropriate surgical treatment.
Literature
1.
go back to reference American Cancer Society (2008) Cancer facts and figures 2008. Atlanta, GA: American Cancer Society American Cancer Society (2008) Cancer facts and figures 2008. Atlanta, GA: American Cancer Society
2.
go back to reference Meyers MA, Oliphant M, Berne AS, Feldberg MA (1987) The peritoneal ligaments and mesenteries: pathways of intraabdominal spread of disease. Radiology 163(3):593–604PubMed Meyers MA, Oliphant M, Berne AS, Feldberg MA (1987) The peritoneal ligaments and mesenteries: pathways of intraabdominal spread of disease. Radiology 163(3):593–604PubMed
3.
go back to reference Meyers MA (1973) Distribution of intra-abdominal malignant seeding: dependency on dynamics of flow of ascitic fluid. Am J Roentgenol Radium Ther Nucl Med 119(1):198–206PubMed Meyers MA (1973) Distribution of intra-abdominal malignant seeding: dependency on dynamics of flow of ascitic fluid. Am J Roentgenol Radium Ther Nucl Med 119(1):198–206PubMed
4.
go back to reference Meyers MA (1976) Dynamic radiology of the abdomen: normal and pathologic anatomy. New York: Springer-Verlag, pp 37–71 Meyers MA (1976) Dynamic radiology of the abdomen: normal and pathologic anatomy. New York: Springer-Verlag, pp 37–71
5.
go back to reference Koppe MJ, Boerman OC, Oyen WJ, Bleichrodt RP (2006) Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies. Ann Surg 243:212–222PubMedCrossRef Koppe MJ, Boerman OC, Oyen WJ, Bleichrodt RP (2006) Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies. Ann Surg 243:212–222PubMedCrossRef
6.
go back to reference Di Giorgio A, Naticchioni E, Biacchi D, et al. (2008) Cytoreductive surgey (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer. Cancer 113:315–325PubMedCrossRef Di Giorgio A, Naticchioni E, Biacchi D, et al. (2008) Cytoreductive surgey (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer. Cancer 113:315–325PubMedCrossRef
8.
go back to reference Sugarbaker PM, Chang D (1999) Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol 6:727–731PubMedCrossRef Sugarbaker PM, Chang D (1999) Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol 6:727–731PubMedCrossRef
9.
go back to reference Glehen O, Kwiatkowski F, Sugarbaker PH, et al. (2004) Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol 22:3284–3292PubMedCrossRef Glehen O, Kwiatkowski F, Sugarbaker PH, et al. (2004) Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol 22:3284–3292PubMedCrossRef
10.
go back to reference Verwaal VJ, Bruin S, Boot H, van Slooten G, van Tinteren H (2008) 8-Year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol 15:2633–2635CrossRef Verwaal VJ, Bruin S, Boot H, van Slooten G, van Tinteren H (2008) 8-Year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol 15:2633–2635CrossRef
11.
go back to reference Esquivel J, Sticca R, Sugarbaker P, et al. (2007) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Society of Surgical Oncology. Ann Surg Oncol 14:128–133PubMed Esquivel J, Sticca R, Sugarbaker P, et al. (2007) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Society of Surgical Oncology. Ann Surg Oncol 14:128–133PubMed
12.
go back to reference Koh JL, Yan TD, Glenn D, Morris DL (2009) Evaluation of preoperative computed tomography in estimating peritoneal cancer index in colorectal peritoneal carcinomatosis. Ann Surg Oncol 16(2):327–333PubMedCrossRef Koh JL, Yan TD, Glenn D, Morris DL (2009) Evaluation of preoperative computed tomography in estimating peritoneal cancer index in colorectal peritoneal carcinomatosis. Ann Surg Oncol 16(2):327–333PubMedCrossRef
13.
go back to reference Levy AD, Shaw JC, Sobin LH (2009) Secondary tumors and tumorlike lesions of the peritoneal cavity: imaging features with pathologic correlation. Radiographics 29(2):347–373PubMedCrossRef Levy AD, Shaw JC, Sobin LH (2009) Secondary tumors and tumorlike lesions of the peritoneal cavity: imaging features with pathologic correlation. Radiographics 29(2):347–373PubMedCrossRef
14.
go back to reference Pannu HK, Bristow R, Montz F, Fishman EK (2003) Multidetector CT of peritoneal cersinomatosis from ovarian cancer. Radiographics 23:687–701PubMedCrossRef Pannu HK, Bristow R, Montz F, Fishman EK (2003) Multidetector CT of peritoneal cersinomatosis from ovarian cancer. Radiographics 23:687–701PubMedCrossRef
15.
go back to reference Funicelli L, Travaini LL, Landoni F, Trifirò G, Bonello L, Bellomi M (2010) Peritoneal carcinomatosis from ovarian cancer: the role of CT and [(18)F] FDG-PET/CT. Abdom Imaging 35(6):701–707PubMedCrossRef Funicelli L, Travaini LL, Landoni F, Trifirò G, Bonello L, Bellomi M (2010) Peritoneal carcinomatosis from ovarian cancer: the role of CT and [(18)F] FDG-PET/CT. Abdom Imaging 35(6):701–707PubMedCrossRef
16.
go back to reference Coakley FV, Choi P, Poturi B, et al. (2002) Peritoneal metastases detection with spiral CT in patient with ovarian cancer. Radiology 223:495–499PubMedCrossRef Coakley FV, Choi P, Poturi B, et al. (2002) Peritoneal metastases detection with spiral CT in patient with ovarian cancer. Radiology 223:495–499PubMedCrossRef
17.
18.
go back to reference Walkey MM, Friedman AC, Sohotra P, Radecki PD (1988) CT manifestation of peritoneal carcinomatosis. AJR Am J Roentgenol 150:1035–1041PubMed Walkey MM, Friedman AC, Sohotra P, Radecki PD (1988) CT manifestation of peritoneal carcinomatosis. AJR Am J Roentgenol 150:1035–1041PubMed
19.
go back to reference Kim SJ, Kim HH, Kim YH, et al. (2009) Peritoneal metastasis: detection with 16- or 64-detector row CT in patients undergoing surgery for gastric cancer. Radiology 253(2):407–415PubMedCrossRef Kim SJ, Kim HH, Kim YH, et al. (2009) Peritoneal metastasis: detection with 16- or 64-detector row CT in patients undergoing surgery for gastric cancer. Radiology 253(2):407–415PubMedCrossRef
20.
go back to reference Sugarbaker PH (1999) Management of peritoneal surface malignancy: the surgeon’s role. Langenbeck’s Arch Surg 384:576–587CrossRef Sugarbaker PH (1999) Management of peritoneal surface malignancy: the surgeon’s role. Langenbeck’s Arch Surg 384:576–587CrossRef
21.
go back to reference Amendola MA (1985) The role of CT in the evaluation of ovarian malignancy. CRC Crit Rev Diagn Imaging 24:329–368 Amendola MA (1985) The role of CT in the evaluation of ovarian malignancy. CRC Crit Rev Diagn Imaging 24:329–368
22.
go back to reference Kyriazi S, Collins DJ, Morgan VA, Giles SL, deSouza NM (2010) Diffusion-weighted imaging of peritoneal disease for noninvasive staging of advanced ovarian cancer. Radiographics 30(5):1269–1285PubMedCrossRef Kyriazi S, Collins DJ, Morgan VA, Giles SL, deSouza NM (2010) Diffusion-weighted imaging of peritoneal disease for noninvasive staging of advanced ovarian cancer. Radiographics 30(5):1269–1285PubMedCrossRef
23.
go back to reference Dromain C, Leboulleux S, Auperin A, et al. (2008) Staging of peritoneal carcinomatosis: enhanced CT vs. PET/CT. Abdom Imaging 33(1):87–93PubMedCrossRef Dromain C, Leboulleux S, Auperin A, et al. (2008) Staging of peritoneal carcinomatosis: enhanced CT vs. PET/CT. Abdom Imaging 33(1):87–93PubMedCrossRef
24.
go back to reference Jacquet P, Jelinek JS, Steves MA, Sugarbaker PH (1993) Evaluation of computed tomography in patients with peritoneal carcinomatosis. Cancer 72(5):1631–1636PubMedCrossRef Jacquet P, Jelinek JS, Steves MA, Sugarbaker PH (1993) Evaluation of computed tomography in patients with peritoneal carcinomatosis. Cancer 72(5):1631–1636PubMedCrossRef
25.
go back to reference Bristow RE, Duska LR, Lambrou NC, et al. (2000) A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography. Cancer 89:1532–1540PubMedCrossRef Bristow RE, Duska LR, Lambrou NC, et al. (2000) A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography. Cancer 89:1532–1540PubMedCrossRef
26.
go back to reference Coakley FV, Hricak H (1999) Imaging of peritoneal and mesenteric disease: key concepts for the clinical radiologist. Clin Radiol 54(9):563–574PubMedCrossRef Coakley FV, Hricak H (1999) Imaging of peritoneal and mesenteric disease: key concepts for the clinical radiologist. Clin Radiol 54(9):563–574PubMedCrossRef
27.
go back to reference Jang YJ, Kim JK, Park SB, Cho KS (2007) Variable CT findings of epithelial origin ovarian carcinoma according to the degree of histologic differentiation. Korean J Radiol 8(2):120–126PubMedCrossRef Jang YJ, Kim JK, Park SB, Cho KS (2007) Variable CT findings of epithelial origin ovarian carcinoma according to the degree of histologic differentiation. Korean J Radiol 8(2):120–126PubMedCrossRef
28.
go back to reference Tempany CM, Zou KH, Silverman SG, et al. (2000) Staging of advanced ovarian cancer: comparison of imaging modalities—report from the Radiological Diagnostic Oncology Group. Radiology 215(3):761–767PubMed Tempany CM, Zou KH, Silverman SG, et al. (2000) Staging of advanced ovarian cancer: comparison of imaging modalities—report from the Radiological Diagnostic Oncology Group. Radiology 215(3):761–767PubMed
29.
go back to reference de Bree E, Koops W, Kröger R, et al. (2004) Peritoneal carcinomatosis from colorectal or appendiceal origin: correlation of pre-operative CT with intraoperative findings and evaluation of interobserver agreement. J Surg Oncol 86(2):64–73PubMedCrossRef de Bree E, Koops W, Kröger R, et al. (2004) Peritoneal carcinomatosis from colorectal or appendiceal origin: correlation of pre-operative CT with intraoperative findings and evaluation of interobserver agreement. J Surg Oncol 86(2):64–73PubMedCrossRef
30.
go back to reference Coakley FV, Hricak H (1999) Imaging of peritoneal and mesenteric disease: key concepts for the clinical radiologist. Clin Radiol 54(9):563–574PubMedCrossRef Coakley FV, Hricak H (1999) Imaging of peritoneal and mesenteric disease: key concepts for the clinical radiologist. Clin Radiol 54(9):563–574PubMedCrossRef
31.
go back to reference Koh DM, Collins DJ (2007) Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol 188(6):1622–1635PubMedCrossRef Koh DM, Collins DJ (2007) Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol 188(6):1622–1635PubMedCrossRef
32.
go back to reference Qayyum A (2009) Diffusion-weighted imaging in the abdomen and pelvis: concepts and applications. Radiographics 29(6):1797–1810PubMedCrossRef Qayyum A (2009) Diffusion-weighted imaging in the abdomen and pelvis: concepts and applications. Radiographics 29(6):1797–1810PubMedCrossRef
33.
go back to reference Russell N, Low MD (2007) MR imaging of the peritoneal spread of malignancy. Abdom Imaging 32:267–283CrossRef Russell N, Low MD (2007) MR imaging of the peritoneal spread of malignancy. Abdom Imaging 32:267–283CrossRef
34.
go back to reference Low RN, Sebrechts CP, Barone RM, Muller W (2009) Diffusion-weighted MRI of peritoneal tumors: comparison with conventional MRI and surgical and histopathologic findings—a feasibility study. AJR Am J Roentgenol 193(2):461–470PubMedCrossRef Low RN, Sebrechts CP, Barone RM, Muller W (2009) Diffusion-weighted MRI of peritoneal tumors: comparison with conventional MRI and surgical and histopathologic findings—a feasibility study. AJR Am J Roentgenol 193(2):461–470PubMedCrossRef
35.
go back to reference Low RN, Gurney J (2007) Diffusion-weighted MRI (DWI) in the oncology patient: value of breathhold DWI compared to unenhanced and gadolinium-enhanced MRI. J Magn Reson Imaging 25(4):848–858PubMedCrossRef Low RN, Gurney J (2007) Diffusion-weighted MRI (DWI) in the oncology patient: value of breathhold DWI compared to unenhanced and gadolinium-enhanced MRI. J Magn Reson Imaging 25(4):848–858PubMedCrossRef
36.
go back to reference Woodhams R, Kakita S, Hata H, et al. (2009) Diffusion weighted imaging of mucinous carcinoma of the breast: evaluation of apparent diffusion coefficient and signal intensity in correlation with histologic findings. AJR Am J Roentgenol 193(1):260–266PubMedCrossRef Woodhams R, Kakita S, Hata H, et al. (2009) Diffusion weighted imaging of mucinous carcinoma of the breast: evaluation of apparent diffusion coefficient and signal intensity in correlation with histologic findings. AJR Am J Roentgenol 193(1):260–266PubMedCrossRef
37.
go back to reference Fujii S, Matsusue E, Kanasaki Y, et al. (2008) Detection of peritoneal dissemination in gynecological malignancy: evaluation by diffusion-weighted MR imaging. Eur Radiol 18(1):18–23PubMedCrossRef Fujii S, Matsusue E, Kanasaki Y, et al. (2008) Detection of peritoneal dissemination in gynecological malignancy: evaluation by diffusion-weighted MR imaging. Eur Radiol 18(1):18–23PubMedCrossRef
Metadata
Title
Peritoneal carcinomatosis: imaging with 64-MDCT and 3T MRI with diffusion-weighted imaging
Authors
F. Iafrate
M. Ciolina
P. Sammartino
P. Baldassari
M. Rengo
P. Lucchesi
S. Sibio
F. Accarpio
A. Di Giorgio
A. Laghi
Publication date
01-08-2012
Publisher
Springer-Verlag
Published in
Abdominal Radiology / Issue 4/2012
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-011-9804-z

Other articles of this Issue 4/2012

Abdominal Radiology 4/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine